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Abstract
Fish oil and shortening have been suggested to have opposite effects on cardiovascular disease (CVD). This study investigated the effect of shortening
and fish oil on CVD risk factors and aorta histopathology, and the association between risk factors and aorta histopathology. Male Wister rats
(n=30) were fed an AIN-93G diet containing 20% fat in the form of fish oil, shortening, or soybean oil for 4 weeks. Total cholesterol (TC), triacylglyceride
(TG), and C-reactive protein levels were significantly (P<0.001) lower in the fish oil than in soybean oil and shortening groups. HDL-cholesterol 
concentrations were significantly different (P<0.001) between groups. In addition, LDL-cholesterol levels were significantly (P<0.001) lower in the
fish oil and shortening groups than in the soybean oil group. Insulin and glucose concentrations did not differ among groups. Effect of dietary
fat on tissue fatty acid composition significantly differed in abdominal fat and brain compared with RBC, heart, kidney and liver. The aortic wall 
was significantly (P=0.02) thinner in the fish oil group than in the soybean oil and shortening groups. The aortic wall thickness was positively 
correlated with TG and TC, but negatively with EPA + DHA levels of all tissues. These results suggested that fish oil had protective effects on 
aorta histopathology by hypolipidemic action in this rat model.
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Introduction5)
Diet has been known as an important risk factor for cardiovascular 
disease (CVD). Studies suggest that fish oil such as 
eicosapentaenoic acid (EPA; C20:5n-3), docosahexaenoic acid 
(DHA; C22:6n-3), and trans fatty acid alter lipoprotein metabolism 
(Colandré et al., 2003; Idris & Sundram, 2002; Morgado et al., 
2005; Othman et al., 2008; Qi et al., 2008) amd insulin resistance 
(Holness  et al., 2003; Kavanagh et al., 2007; Mahmud et al., 
2004; Natarajan et al., 2005). Previous studies reported that fish 
oil lowered total cholesterol (TC), low-density lipoprotein 
(LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, 
and triacylglycerol (TG) concentrations (Morgado
  et al., 2005; 
Othman et al., 2008; Qi et al., 2008;). On the other hand, trans 
fatty acids increased LDL-cholesterol, TC, and TG (Colandré et 
al., 2003; Idris & Sundram, 2002; Natarajan et al., 2005) and 
decreased HDL-cholesterol (Idris & Sundram, 2002). There were 
several studies to show the effects of fish oil and trans fatty 
acids on insulin and glucose, but the findings were inconclusive. 
Holness et al. (2003) reported that n-3 fatty acids decreased insulin 
and increased glucose levels, but Mahmud et al. (2004) did not. 
Trans fatty acids decreased insulin levels in some studies (Ibrahim 
et al., 2005; Natarajan et al., 2005), but not in others (Bernal 
et al., 2006; Lichtenstein et al., 2003). 
Inflammation is another risk factor for CVD and a few human 
studies have shown that n-3 fatty acids decrease (Ciubotaru et 
al., 2003; Niu et al., 2006) and trans fatty acids increase 
C-reactive protein (CRP; Baer et al., 2004; Lopez-Garcia et al., 
2005). Unfortunately, there is no animal study showing the 
effects of fish oil and trans fatty acids on CRP. Unlikely with 
lipid profile, insulin, or CRP, vascular morphology is an 
intermediate marker of CVD (Cao et al., 2007). There has been 
only one study reporting that vascular wall thickness and 
coronary artery diameter were decreased in DHA-fed rats. 
Therefore, we investigated the effect of shortening and fish oil 
on CVD risk factors and aorta histopathology, and the association 
between risk factors and aorta histopathology. 
Materials and Methods
Animals and diet
Four-week-old male Wistar rats (Japan SLC. Inc., Japan) 
weighing 100-120 g were fed a commercial chow diet for one 
week and randomly assigned to one of three groups (n=10 each) 
for four weeks. Throughout the experiment, rats were housed 
in standard stainless cages and maintained in a temperature- 
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Table 1. Composition of experimental diets
1
(g/kg) Soybean oil Fish oil  Shortening
Starch 399.3 399.3 399.3
Casein 200 200 200
Sucrose 100 100 100
Rapeseed oil 30 30 30
Soybean oil 170
Fish oil 170
Shortening 170
F i b e r 5 05 05 0
Mineral mix
2 35 35 35
Vitamin mix
2 10 10 10
L-systein-L-metionine 3 3 3
Choline 2.5 2.5 2.5
Butylated hydroxytuoluen 0.2 0.2 0.2
1 Animals  were  fed  an  isocaloric  semi-synthetic  diet  containing  identical  dietary 
c o n s t i t u e n t s  d if f e r i n g  o n l y  in  t h e  c o m p o s i t io n  o f  d i e t a r y  o i l for  4  weeks.
2 Mineral  mix  and  Vitamin  mix  were  prepared  according  to  the  AIN-93  (23).
controlled animal facility at 22 ± 1℃ with a 12-h light/dark cycle 
and humidity-controlled at 60 ± 10%. Daily intake was calculated 
by subtracting residual food from the amount given. Body weight 
was measured twice a week. Rats were housed two per cage 
and fed with one of three isocaloric purified AIN-93G diets ad 
libitum, which were stored at -5℃ temperature and replaced with 
fresh diets every day (Reeves et al., 1993). The experimental 
diet contained 20% fat from soybean oil (Back-Seol, CJ, Korea), 
fish oil (Carlson the very finest fish oil, Carlson lab, Norway), 
or shortening (Crisco, JM Smuckers Company, USA; Table 1). 
The fatty acid composition of fish oil was 27.2% n-3 fatty acids, 
17.0% saturated fat (SFA), 34.0% polyunsaturated fat (PUFA), 
and 17.0% monounsaturated fat (MUFA). The fatty acid 
composition of shortening was 10.6% trans fatty acids, 21.2% 
SFA, 21.2% PUFA, and 28.33 MUFA. After four weeks, the 
rats were deprived of food overnight and carbon dioxide 
asphyxiated. The experimental protocols were approved by the 
Animal Care Committee of Hanyang University.
Procedures
Blood samples were collected in EDTA and SST tubes by cardiac 
puncture. Plasma and serum were separated by centrifugation at 
3,000 g for 15 min (HA1000-3, Hanil Sciences Industrial Co. 
Ltd., Korea) and stored at <-70℃ for later analysis. Serum TG, 
TC, and plasma HDL-cholesterol levels were measured by 
enzymatic methods (Ultrospec 2100 pro, Amersham Pharmacia 
Biotech, England). Serum LDL-cholesterol concentrations were 
calculated using the Friedewald equation (Friedewald et al., 1972). 
Plasma insulin (EIA kit, SPI bio, France), CRP (BD
TM  ELISA, 
BD Biosciences, USA) and serum glucose (Glucose Assay Kit, 
Biovision, USA) levels were measured by enzyme immunoassay 
at 415, 450, and 570 nm, respectively with microplate reader 
(ELx 800 uv, BIO-TEK Instruments. INC, USA).
Liver, brain, kidney, heart, and abdominal fat (100 mg) were 
mixed with 5ml of chloroform: methanol: distilled water, 2:2:1 
(v/v/v). Tissue phospholipids were separated by thin layer 
chromatography (TLC; Silica gel G, Analtech, USA) and re- 
extracted by hexane: ether: acetic acid, 40:10:1 (v/v/v). Red blood 
cells (RBC) and tissue phospholipids were methylated by adding 
boron trifluoride methanol-benzene (B1252; Sigma-Aldrich, MO, 
USA), and heated at 100℃ for 10 min. Fatty acid methyl esters 
were analyzed by Gas Chromatography (GC; Shimadzu 2010AF; 
Shimadzu Scientific Instrument, Japan) with a 100-m SP2560 
capillary column (Supelco; Bellefonte, PA, USA). Fatty acids 
were identified by comparison with known standards (GLC-727; 
Nu-Check Prep, Elysian, MN, USA). The C18:1t standard were 
the mixture of C18:1n-12t, C18:1n-9t, and C18:1n-7t, and the 
C18:2n-6t standard contained 18:2n-6tt. The control sample was 
made from pooled RBC and the CV was 4.6%. 
Portions of aortic tissue were fixed in 10% formalin in pH 
7.4 (Kim et al., 1995). The washed tissue was dehydrated in 
descending isopropanol grades, cleared in xylene, and embedded 
in paraffin. Sections were cut to be 5 μm thick and stained with 
hematoxylin, eosin, Venhoeff, and Van Gieson. Haematoxylin 
stains cell nuclei blue, while eosin stains cytoplasm, connective 
tissue and other extracellular substances pink or red. Eosin is 
strongly absorbed by red blood cells, coloring them bright red. 
Van Gieson's and Venhoeff stain is a mixture of picric acid and 
acid fuchsin. The sections were viewed under a light microscope 
(DM RXE, Leica, Germany) for histopathological changes. 
Intima wall thickness, media, and lumen area were examined 
at 0°, 90°, 180° and 270° in every section and the average 
measure was calculated (Analysis v.3.2, SIS Gmbh, Germany).
Statistical analysis
All data were expressed as the mean ± SEM, and differences 
among the three groups were compared using one-way ANOVA 
with post-hoc Turkey’s test. A p-value of <0.05 was considered 
statistically significant. Statistical analysis was performed using 
SPSS software version 12 (SPSS Inc., Chicago, IL, USA).
Results
Rat weight, diet, and weight of organs
Average daily weight, initial and final body weight, weight 
change, and heart and brain weights did not significantly differ 
among groups (Table 2). Rats fed fish oil had significantly lower 
abdominal fat weight, but significantly higher liver and kidney 
weights, as compared with those fed soybean oil or shortening.
Lipid profile, insulin, glucose, and CRP
TC, TG, and CRP concentrations were significantly lower in 
the fish oil than the soybean oil and shortening groups (Table 104 Fish oil and cardiovascular risk
Table 2. Dietary intake, body weight, and organ weights
Soybean oil Shortening Fish oil
Dietary intake (g/day)  16.6 ± 0.7
1  16.8 ± 0.4  16.0 ± 0.4
Initial body weight (g) 111.6 ± 2.0 111.9 ± 2.1 111.5 ± 1.9
Final body weight (g) 290.7 ± 7.6 291.1 ± 6.4 286.5 ± 8.3
Weight gain (g) 179.1 ± 6.7 179.2 ± 5.4 175.0 ± 7.1
Liver weight (g)  10.5 ± 0.4
a2   9.9 ± 0.4
a  12.5 ± 0.5
b
Kidney weight (g)   2.3 ± 0.1
a   2.3 ± 0.1
a   2.6 ± 0.1
b
Heart weight (g)   1.2 ± 0.0   1.2 ± 0.0   1.2 ± 0.1
Brain weight (g)   1.7 ± 0.1   1.8 ± 0.1   0.9 ± 0.0
Abdominal fat weight (g)   4.3 ± 0.3
a   3.6 ± 0.2
a   1.8 ± 0.2
b
1 Data  were  expressed  as  mean ± SEM  of  10  rats  per  group.
2 Values in a row with different letters were significantly different, P<0.05 (ANOVA 
with  post-hoc  Tukey’s  test).
Table 3. Lipid profile, insulin, glucose, and C-reactive protein
Soybean oil Shortening Fish oil
TC
1 (mg/dL) 133.10 ± 7.98
a2,3 117.80 ± 6.12
a 52.00 ± 3.55
b
TG (mg/dL) 206.90 ± 17.58
a 194.10 ± 21.14
a 94.60 ± 10.49
b
HDL-cholesterol (mg/dL)  38.65 ± 2.69
a  58.28 ± 1.76
c 13.98 ± 2.46
b
LDL-cholesterol (mg/dL)  53.07 ± 7.22
a  20.70 ± 3.71
b 19.10 ± 2.69
b
Insulin (ng/mL)   2.26 ± 0.19   2.54 ± 0.22  2.32 ± 0.21
Glucose (nmol/μL)   6.43 ± 0.75   7.37 ± 0.90  7.63 ± 0.82
CRP (mg/dL)  38.13 ± 1.14
a  35.76 ± 0.58
a 29.52 ± 0.81
b
Aorta thickness (μm)  86.38 ± 2.07
a  87.93 ± 3.67
a 72.98 ± 2.74
b
1 TC,  total  cholesterol;  TG,  triacylglyceride;  HDL-cholesterol,  high-density 
lipoprotein-cholesterol;  LDL-cholesterol,  low-density  lipoprotein-cholesterol; CRP, 
C-reactive  protein
 
2 Data  were  expressed  as  mean ± SEM  of  10  rats  per  group.
3 Values in a row with different letters were significantly different, P<0.01 (ANOVA 
with  post-hoc  Tukey’s  test).
Table 4. Fatty acid composition of red blood cell and other tissues
(%) Soybean oil Shortening Fish oil
Red blood cell
C18:3n3  5.57 ± 0.65
1  4.77 ± 0.70  4.81 ± 0.61
C20:5n3 (EPA
2)  0.35 ± 0.01
a3  0.25 ± 0.01
a 11.86 ± 0.44
b
C22:5n3  1.80 ± 0.04
a  1.75 ± 0.05
a  3.02 ± 0.08
b
C22:6n3 (DHA)  3.26 ± 0.06
a  3.71 ± 0.10
b  8.98 ± 0.49
c
EPA + DHA  3.61 ± 0.05
a  3.96 ± 20.84
a 20.84 ± 0.52
b
Total n-3 FAs 10.97 ± 0.63
a 10.48 ± 0.71
a 28.67 ± 0.36
b
C16:1n7t  0.03 ± 0.00
a  0.11 ± 0.01
b  0.21 ± 0.01
c
C18:1t  0.40 ± 0.01
a  2.15 ± 0.09
b  0.21 ± 0.01
a
C18:2n6t  0.27 ± 0.02
a  0.20 ± 0.02
b  0.31 ± 0.01
a
Total trans FAs  0.69 ± 0.05
a  2.46 ± 0.21
b  0.74 ± 0.07
a
Liver
C18:3n3  0.17 ± 0.02
a  0.08 ± 0.01
b  0.08 ± 0.00
b
C20:5n3  0.09 ± 0.01
a  0.05 ± 0.00
a  4.60 ± 0.41
b
C22:5n3  0.81 ± 0.03
a  0.72 ± 0.04
a  1.16 ± 0.10
b
C22:6n3  9.31 ± 0.26
a  8.28 ± 0.36
a 21.28 ± 0.70
b
EPA + DHA  9.40 ± 0.25
a  8.34 ± 0.35
a 25.88 ± 0.77
b
Total n-3 FAs 10.38 ± 0.22
a  9.13 ± 0.36
a 27.13 ± 0.73
b
C16:1n7t  0.03 ± 0.00
a  0.11 ± 0.01
c  0.08 ± 0.04
b
C18:1t  0.13 ± 0.01
a  1.90 ± 0.03
b  0.13 ± 0.00
a
C18:2n6t  0.00 ± 0.00
a  0.01 ± 0.00
b  0.00 ± 0.00
a
Total trans FAs  0.16 ± 0.02
a  2.02 ± 0.09
b  0.21 ± 0.02
a
Kidney
C18:3n3  0.58 ± 0.04
a  0.21 ± 0.02
b  0.19 ± 0.02
b
C20:5n3  0.37 ± 0.02
a  0.18 ± 0.01
a 12.17 ± 0.89
b
C22:5n3  0.42 ± 0.02
a  0.38 ± 0.02
a  1.03 ± 0.06
b
C22:6n3  2.62 ± 0.05
a  2.43 ± 0.09
a 10.38 ± 0.51
b
EPA + DHA  2.99 ± 0.06
a  2.61 ± 0.10
a 22.55 ± 1.30
b
Total n-3 FAs  4.00 ± 0.08
a  3.20 ± 0.10
a 23.77 ± 1.28
b
C16:1n7t  0.05 ± 0.01
a  0.39 ± 0.04
c  0.17 ± 0.01
b
C18:1t  0.36 ± 0.03
a  1.89 ± 0.26
b  0.17 ± 0.02
a
C18:2n6t  0.22 ± 0.02
a  0.10 ± 0.01
b  0.08 ± 0.01
b
Total trans FAs  0.63 ± 0.12
a  2.39 ± 0.94
b  0.40 ± 0.09
a
Heart
C18:3n3  0.20 ± 0.00
a  0.11 ± 0.01
b  0.13 ± 0.01
b
C20:5n3  0.06 ± 0.00
a  0.04 ± 0.00
a  2.40 ± 0.06
b
C22:5n3  2.74 ± 0.11
a  2.54 ± 0.08
a  2.02 ± 0.03
b
C22:6n3 14.30 ± 0.22
a 14.29 ± 0.37
a 28.56 ± 0.42
b
EPA + DHA 14.36 ± 0.22
a 14.33 ± 0.37
a 30.95 ± 0.39
b
Total n-3 FAs 17.30 ± 0.23
a 16.98 ± 0.36
a 33.10 ± 0.38
b
C16:1n7t  0.04 ± 0.01
a  0.09 ± 0.01
b  0.13 ± 0.01
c
C18:1t  0.29 ± 0.01
a  1.96 ± 0.04
c  0.15 ± 0.01
b
C18:2n6t  0.28 ± 0.02
a  0.10 ± 0.01
b  0.08 ± 0.01
c
Total trans FAs  0.61 ± 0.07
a  2.15 ± 0.14
b  0.36 ± 0.06
c
Brain
C18:3n3  0.02 ± 0.01  0.00 ± 0.00  0.02 ± 0.01
C20:5n3  0.00 ± 0.00
a  0.00 ± 0.00
a  0.37 ± 0.02
b
C22:5n3  0.10 ± 0.03
a  0.19 ± 0.01
a  0.87 ± 0.03
b
C22:6n3 17.18 ± 0.61
a 17.68 ± 0.33
a 20.97 ± 0.39
b
EPA + DHA 17.18 ± 0.61
a 17.69 ± 14.33
a 21.33 ± 30.95
b
Total n-3 FAs 17.31 ± 0.59
a 17.88 ± 0.33
a 22.22 ± 0.37
b
C16:1n7t  0.04 ± 0.00
a  0.15 ± 0.02
b  0.10 ± 0.02
ab
C18:1t  0.06 ± 0.02
a  0.03 ± 0.02
b  0.14 ± 0.02
c
C18:2n6t  0.23 ± 0.03
a  0.30 ± 0.04
a  0.05 ± 0.01
b
Total trans FAs  0.33 ± 0.13
a  0.75 ± 0.10
b  0.29 ± 0.08
a
Abdominal fat
C18:3n3  0.68 ± 0.07
a  0.46 ± 0.09
ab  0.42 ± 0.05
b
C20:5n3  0.05 ± 0.01
a  0.00 ± 0.00
a  4.69 ± 0.25
b
C22:5n3  0.10 ± 0.02
a  0.00 ± 0.00
a  1.71 ± 0.16
b
C22:6n3  1.52 ± 0.14
a  0.00 ± 0.00
b  6.96 ± 0.29
c
EPA + DHA  1.57 ± 0.13
a  0.00 ± 0.00
b 11.65 ± 0.42
c
Total n-3 FAs  2.35 ± 0.13
a  0.46 ± 0.09
b 13.77 ± 0.48
c
C16:1n7t  0.13 ± 0.02  0.19 ± 0.03  0.18 ± 0.01
C18:1t  1.24 ± 0.14
a  5.77 ± 0.37
b  0.52 ± 0.16
a
C18:2n6t  0.24 ± 0.03
a  0.25 ± 0.02
a  0.06 ± 0.02
b
Total trans FAs  1.61 ± 0.50
a  6.22 ± 1.20
b  0.77 ± 0.55
a
1 Data  were  expressed  as  mean ± SEM  of  ten  rats  per  group.
2 EPA,  eicosapentaenoic  acid;  DHA,  docosahexaenoic  acid;  FA,  fatty  acid
3 Values in a row with different letters were significantly different, P<0.05 (ANOVA 
with  post-hoc  Turkey’s  test).
3). HDL-cholesterol level was the lowest in the fish oil group 
and the highest in the shortening group. LDL-cholesterol level 
was significantly lower in the fish oil and shortening groups than 
the soybean oil group. There was no significant difference in 
insulin or glucose levels among groups.
Fatty acids composition of tissues
Total n-3 fatty acids, EPA, DPA, DHA and EPA+DHA in 
RBC, liver, kidney, heart, brain, and abdominal fat were 
significantly higher in the fish oil than soybean oil and shortening Seonhye Park
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(a) (b)
(c)
Fig. 1. Aorta wall stained by Venhoeff & van Gieson in rats; (a) soybean oil; 
(b) fish oil; (c) shortening
 
(a) (b)
(c)
Fig. 2. Aorta wall stained by Hematoxylin-eosin staining in rats; (a) soybean 
oil; (b) fish oil; (c) shortening
Table 5. Cardiovascular risk factors according to tertile of aortic wall thickness
Aortic wall thickness tertile (μm)
12 3
Aortic lumen area (mm
2)  1 . 1 3 ± 0 . 0 7
1   1.06 ± 0.06   1.11 ± 0.04
TC
2 (mg/dL)  69.00 ± 11.72
a3 109.75 ± 14.50
ab 123.75 ± 9.08
b
TG (mg/dL) 117.86 ± 19.14
a 183.13 ± 20.56
ab 196.13 ± 20.10
b
HDL-cholesterol (mg/dL)  25.02 ± 7.01  37.77 ± 8.11  46.33 ± 4.68
LDL-cholesterol (mg/dL)  20.40 ± 2.21  35.35 ± 8.81  38.19 ± 9.13
Insulin (ng/mL)   2.00 ± 0.22   2.67 ± 0.10   0.52 ± 0.30
Glucose (nmol/μL)   7.61 ± 1.03   6.40 ± 0.68   7.17 ± 0.52
CRP (mg/dL)  31.92 ± 1.20  35.19 ± 2.16  35.47 ± 0.97
EPA + DHA (%)
RBC  16.04 ± 2.59
a   8.56 ± 3.19
ab   3.71 ± 0.06
b
Liver  22.09 ± 3.09
a  13.14 ± 2.64
b   9.05 ± 0.49
b
Brain  20.50 ± 0.74
a  18.56 ± 0.78
ab  17.73 ± 0.61
b
Heart  27.28 ± 2.64
a  18.07 ± 2.57
b  14.52 ± 0.35
b
Kidney  18.64 ± 3.82
a   7.10 ± 2.80
b   2.95 ± 0.06
b
Abdominal fat   9.19 ± 2.03
a   3.52 ± 2.03
b   0.79 ± 0.32
b
1 Data  were  expressed  as  mean ± SEM. 
2 RBC, red blood cell; TC, total cholesterol; TG, triacylglyceride; HDL-cholesterol, 
high  density  lipoprotein-cholesterol;  LDL-cholesterol,  low  density 
lipoprotein-cholesterol;  CRP,  C-reactive  protein;  RBC,  red  blood  cell;  EPA, 
eicosapentaenoic  acid;  DHA,  docosahexaenoic  acid
3 Values in a row with different letters were significantly different, P<0.05 (ANOVA 
with  post-hoc  Turkey’s  test).
groups (Table 4). However, alpha-linolenic acids (ALA; 
C18:3n3) in the liver, kidney, heart, and abdominal fat were 
significantly higher in the soybean oil than fish oil and shortening 
groups. Total trans fatty acids, C16:1n7t and C18:1t in RBC, 
liver, kidney, brain, and abdominal fat, and C18:1t in abdominal 
fat were significantly higher in the shortening than fish oil and 
soybean oil groups. Interestingly, there was no consistent pattern 
in the distribution of C18:2n6t. Dietary effect on fatty acid 
composition of RBC was similar to those of liver, kidney and 
heart, but to those of abdominal and brain, suggesting that dietary 
fatty acid composition highly influenced abdominal fatty acid 
composition but less influenced brain fatty acid composition. 
Aorta histopathology 
Aortic wall thickness was significantly lower in the fish oil 
than soybean oil and shortening groups (Table 3). The density 
of tunica media smooth muscle nuclei was significantly higher 
in the fish oil than soybean oil and shortening groups (Fig. 1). 
In addition, tunica media smooth muscle nuclei in the fish oil 
group were longer and finer than those in the other groups. The 
aortic wall lumen area and number of elastin bands did not differ 
significantly among groups (Fig. 2). The aortic wall thickness 
was positively correlated with TG and TC, and negatively 
correlated with EPA+DHA in RBC, liver, heart, kidney, brain, 
and abdominal fat (Table 5). There was no significant association 
between aortic wall thickness and trans fatty acids (data not 
shown).
Discussion
Aortic wall was significantly thinner, and TC, HDL- 
cholesterol, TG, and CRP levels were significantly lower in the 
fish oil group than the soybean oil and shortening groups in this 
study. Aortic wall thickness was negatively associated with n-3 
fatty acids of all tissues, but positively associated with TC and 
TG concentrations. Interestingly, HDL-cholesterol level was 
higher and LDL-cholesterol was lower in the shortening group 
than the soybean oil group, but there was no association between 
trans fatty acids and aortic wall thickness. 
Increased wall thickness is a common structural feature of 
hypertensive resistant vessels (Folkow, 1990) and conduit arteries 
such as the aorta (Chamiot-Clerc et al., 2001). Hypertensive 
structural alterations of the aortic wall may affect arterial 
mechanics. Fish intake has been shown to reduce coronary artery 
atherosclerosis progression (Erkkilä et al., 2004), while trans fat 106 Fish oil and cardiovascular risk
accelerated it (Merchant et al., 2008). Engler et al. (2003) also 
showed previously that supplementation of DHA decreased 
vascular wall thickness, but there was no other study to 
investigate the effect of trans fatty acids or fish oil on aorta 
pathophysiology.
Previous studies consistently found that fish oil consumption 
decreased TG, TC, LDL-cholesterol, and HDL-cholesterol (Lu 
et al., 1996; Morgado
  et al., 2005). On the other hands, trans 
fatty acids has been shown to increase TG, TC, and LDL-cholesterol 
concentration and decrease HDL-cholesterol (Colandré et al., 2003; 
Ibrahim et al., 2005; Idris & Sundram, 2002; Natarajan et al., 
2005). However, we observed that shortening increased 
HDL-cholesterol, but decreased LDL-cholesterol as compared to 
those fed soybean oil (Table 3). This inconsistency may be partly 
caused by either that we used young rats and shortening made 
from soybean oil, or fed diet not long enough or that we did 
not separated HDL 2 and 3 .
Anti-inflammatory effect of n-3 fatty acids have been studied 
in human models and CRP levels are believed to reflect a chronic, 
low-grade inflammatory process, and associated with increased 
CVD (Ciubotaru et al., 2003; Niu et al., 2006; Zampelas et al., 
2005). Trans fatty acids, however, have been known as 
pro-inflammatory (Mozaffarian et al., 2004). A few clinical 
studies (Baer et al., 2004; Mozaffarian et al., 2004) demonstrated 
that CRP was positively associated with trans fat intake. There 
was no animal study to show the effects of fish oil and shortening 
on CRP, but we found that fish oil consistently reduced CRP 
in this rat model but shortening did not.
It is well documented that membrane fatty acid composition 
is modified by diet (Hulbert et al., 2005). In the present study, 
dietary effect on fatty acid composition of RBC was similar to 
those of liver, kidney and heart, but to those of abdominal and 
brain, suggesting that dietary fatty acid composition highly 
influenced abdominal fatty acid composition but less influenced 
brain fatty acid composition (Table 4). Baylin and Campos (2006) 
previously reported that the fatty acid composition of adipose 
tissue was considered to be the best choice for the assessment 
of long-term dietary intake of fatty acids due to a slow turnover 
rate, with blood fractions reflecting shorter-term intake. 
Porsgaard  et al. (2007) found that the fatty acid composition 
of the brain and adipose tissue was not highly affected by dietary 
fats, because of slow fatty acid turnover. Once DHA is 
synthesized in the brain, it is very efficiently retained, and thus 
is not easily affected by dietary fatty acids (Bazan et al., 1993). 
Additionally, Edmond et al. (1998) found that the activities of 
Δ5 and Δ6-desaturase in the brain, the rate-limiting step in n-3 
fatty acid synthesis, did not significantly differ between rats fed 
n-3 PUFA adequate and deficient diets.
Interestingly, abdominal fat was significantly lower in rats fed 
fish oil as compared with the rats fed shortening or soybean oil 
in the present study (Table 2). It was consistent with lower CRP 
levels in rats fed fish oil. Previous studies have also suggested 
that fish oil decreased abdominal, epididymal, and lumbar fat 
by altering hepatic lipogenic genes and fatty acid oxidation 
(Halvorsen et al., 2001; Jang et al., 2003; Rustan et al., 1998; 
Ruzickova et al., 2004). Although our study did not significantly 
decrease body weight, rats fed fish oil were weighed less.
Unfortunately, we did not find significant changes in insulin 
and glucose concentrations after feeding fish oil or shortening 
(Table 3). This finding, however, was not surprising since the 
effects of fish oil and trans fatty acids on insulin and glucose 
levels have been inconsistent. Mahmud et al. (2004) reported 
that fish oil increased insulin levels in non-diabetic rats but 
decreased in diabetic rats, with no effect on glucose levels. 
Holness et al. (2003) demonstrated that n-3 fatty acids decreased 
insulin and increased glucose concentration in Wister rats. Trans 
fats also have been shown to decrease (Ibrahim et al., 2005; 
Natarajan  et al., 2005) and increase (Alstrup et al., 1999; 
Lichtenstein  et al., 2003) insulin levels. 
In conclusion, aortic wall thickness was positively correlated 
with TG and TC, but negatively with EPA + DHA levels of 
all tissues, suggesting that fish oil had cardio-protective effects 
on aorta histopathology by hypolipidemic action in this rat model. 
Shortening had some beneficial effects on lipid profile, but no 
effect on aorta histopathology.
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